Autoimmune Diseases Clinical Trials in Nanjing, Jiangsu
3 recruitingNanjing, Jiangsu, China
Showing 1–3 of 3 trials
Recruiting
Early Phase 1
A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases
Autoimmune Diseases
Ruijin Hospital66 enrolled3 locationsNCT06747156
Recruiting
Early Phase 1
A Study of LUCAR-DKS1 in Subjects With Relapsed/Refractory Autoimmune Diseases
Relapsed/Refractory Autoimmune Diseases
Nanjing Legend Biotech Co.36 enrolled5 locationsNCT07095075
Recruiting
Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
Autoimmune DiseasesAutoinflammatory Diseases
Peking Union Medical College Hospital20,000 enrolled9 locationsNCT06417502